Guangwen Cao

Years Active: 2018-2018
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Yong Luo, Abul Kalam Azad, Styliani Karanika, Spyridon P Basourakos, Xuemei Zuo, Jianxiang Wang, Luan Yang, Guang Yang, Dimitrios Korentzelos, Jianhua Yin, Sanghee Park, Penglie Zhang, James J Campbell, Thomas J Schall, Guangwen Cao, Likun Li, Timothy C Thompson
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models. International journal of cancer 142 (10) (2018)

Guangwen Cao.css-eqlu8i{font-size:small;padding-left:4px;}